ArticlePloS one2019

The activation of retinal HCA2 receptors by systemic beta-hydroxybutyrate inhibits diabetic retinal damage through reduction of endoplasmic reticulum stress and the NLRP3 inflammasome.

Maria Consiglia Trotta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.